Dova Pharmaceuticals Inc. (DOVA) Fundamental Analysis & Valuation
NASDAQ:DOVA
Current stock price
28.04
+0.04 (+0.14%)
At close:
28.04
0 (0%)
After Hours:
This DOVA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
No Fundamental Analysis report for DOVA not available.
DOVA Fundamentals: All Metrics, Ratios and Statistics
28.04
+0.04 (+0.14%)
Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners33.03%
Inst Owner Change0%
Ins Owners43.01%
Ins Owner Change0%
Market Cap807.61M
Revenue(TTM)13.73M
Net Income(TTM)-74.06M
Analysts76
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)0%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 58.81 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 24.3 | ||
| P/tB | N/A | ||
| EV/EBITDA | -10.72 |
EPS(TTM)-2.56
EYN/A
EPS(NY)-1.8
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.48
BVpS1.15
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -93.81% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | -531.55% | ||
| PM (TTM) | -539.32% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.9 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.08 | ||
| Quick Ratio | 4.77 | ||
| Altman-Z | 5.25 |
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
EPS Next Y6.15%
EPS Next 2Y16.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)82.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A
Dova Pharmaceuticals Inc. / DOVA Fundamental Analysis FAQ
What is the fundamental rating for DOVA stock?
ChartMill assigns a fundamental rating of 3 / 10 to DOVA.
What is the valuation status of Dova Pharmaceuticals Inc. (DOVA) stock?
ChartMill assigns a valuation rating of 0 / 10 to Dova Pharmaceuticals Inc. (DOVA). This can be considered as Overvalued.
What is the profitability of DOVA stock?
Dova Pharmaceuticals Inc. (DOVA) has a profitability rating of 0 / 10.
What is the financial health of Dova Pharmaceuticals Inc. (DOVA) stock?
The financial health rating of Dova Pharmaceuticals Inc. (DOVA) is 5 / 10.
How sustainable is the dividend of Dova Pharmaceuticals Inc. (DOVA) stock?
The dividend rating of Dova Pharmaceuticals Inc. (DOVA) is 0 / 10 and the dividend payout ratio is 0%.